Key result
High-dose insulin/glucose therapy reverses cardiotoxicity from beta-blocker and CCB overdoses when standard therapies fail.
Why the study?
Does high-dose insulin/glucose therapy reverse the cardiotoxic effects of β-blocker and calcium channel blocker poisoning?
Does high-dose insulin/glucose therapy reverse the cardiotoxic effects of β-blocker and calcium channel blocker poisoning?
High-dose insulin/glucose therapy is an effective and relatively safe treatment for severe β-blocker and calcium channel blocker poisoning refractory to standard therapies.
Overdoses of β-blockers and calcium channel blockers can produce significant morbidity and mortality, and conventional therapies often do not work as treatments for these poisonings. High-dose insulin/glucose therapy has been successful in reversing the cardiotoxic effects of these drugs in cases where the standard therapies have failed, and it appears to be relatively safe. Many successes have been well documented, but the clinical experience consists of case reports, the mechanisms of action are not completely understood, and guidelines for use of the therapy are empirically derived and not standardized. Regardless of these limitations, high-dose insulin/glucose therapy can be effective, it is often recommended by clinical toxicologists and poison control centers, and critical care nurses should be familiar with when and how the therapy is used.
No takes yet. Share an insight, caveat, or question.
Dana Bartlett (2016) conducted a review in β-blocker and calcium channel blocker poisoning. High-dose insulin/glucose therapy vs. Conventional therapies was evaluated on Reversal of cardiotoxic effects. High-dose insulin/glucose therapy can successfully reverse the cardiotoxic effects of beta-blocker and calcium channel blocker overdoses when standard therapies fail.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: